Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Transcutaneous Afferent Patterned Stimulation (TAPS) for Reduction of Parkinson's Disease (PD) Related Action Tremor

Trial N/A Completed Feb. 12, 2024

Development and Validation of a Scale Measuring Preoperative Expectations in Parkinson's Disease

Trial N/A Completed Feb. 11, 2024

Acute Effects of Strength Training and High Intensity Training on Functional and Biochemical Measurements of Individuals With Parkinson's Disease in Different Environments and Depths

Trial N/A Unknown Feb. 11, 2024

Domperidone and Risk of Sudden Cardiac Death

Trial N/A Completed Feb. 8, 2024

High-Dose Ambroxol in GBA1-Related Parkinson

Trial Phase 1 Unknown Feb. 7, 2024

Multiple-dose Trial to Determine the Clinical Bioequivalence Between Tavapadon Tablets in Participants With Parkinson's Disease

Trial Phase 1 Completed Feb. 7, 2024

Microbiome Composition and Function Contributes to Cognitive Impairment and Neuroinflammation in Parkinson's Disease

Trial N/A Unknown Feb. 7, 2024

Social Cognition Dysfunctions in Parkinson's Disease

Trial N/A Completed Feb. 6, 2024

Reliability and Validity Studies of Turkish Version of Manual Ability Measure-36

Trial N/A Completed Feb. 5, 2024

Interleaving Stimulation Improves Dyskinesia in Parkinson's Disease

Trial N/A Unknown Feb. 1, 2024

Impact of a Standardized Music Therapy Protocol on the Quality of Life of Patients With Abnormal Movements Treated With Continuous Electrical Neuromodulation

Trial N/A Terminated Feb. 1, 2024

Remote Monitoring in Parkinson's Disease

Trial N/A Completed Feb. 1, 2024

Vibrotactile Foot Device for Freezing of Gait in Parkinson's Disease

Trial N/A Unknown Feb. 1, 2024

Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease

Trial Phase 4 Unknown Jan. 31, 2024

Stress ECG Test for the Evaluation of the Risk of Sudden Cardiac Death in a Paediatric Cohort With WPW Pattern

Trial N/A Terminated Jan. 31, 2024

Single-center Pathophysiological Study of the Role of Inflammation, Changes in the Intestinal Epithelial Barrier and the Intestinal Microbiota in Parkinson's Disease

Trial N/A Terminated Jan. 31, 2024

Exploring Brain Molecular Imaging and Blood Biomarkers in Subjects With Glucocerebrosidase Mutations: Toward a Precision Medicine Approach to Characterize Parkinson's Disease Clinical Trajectories

Trial N/A Unknown Jan. 31, 2024

Clinical Study of Stellate Ganglion Block in Treatment of Patients With Advanced Primary Parkinson's Disease

Trial N/A Unknown Jan. 30, 2024

The Effects of Sertraline on Depression in Parkinson's Disease

Trial N/A Completed Jan. 29, 2024

Deciphering the Impact of Exposures From the Gut Microbiome-derived Molecular Complex in Human Health and Disease

Trial N/A Completed Jan. 28, 2024